CisplatinCell DeathAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsApoptosisCombined Modality TherapyCause of DeathTreatment OutcomeDoxorubicinEtoposideCyclophosphamideLung NeoplasmsDrug Administration ScheduleDrug Resistance, NeoplasmSurvival AnalysisCell SurvivalCell Line, TumorDisease-Free SurvivalPaclitaxelCaspasesSurvival RateVinblastineNeoadjuvant TherapyNeoplasm StagingPlatinumCarboplatinDeoxycytidineBreast NeoplasmsOvarian NeoplasmsDeathPrognosisTaxoidsIfosfamideNeoplasmsTime FactorsDose-Response Relationship, DrugCaspase 3Proto-Oncogene Proteins c-bcl-2MethotrexateCarcinoma, Non-Small-Cell LungNeoplasm Recurrence, LocalNecrosisBleomycinVomitingAntineoplastic Agents, PhytogenicInduction ChemotherapyTumor Cells, CulturedAdenocarcinomaAntimetabolites, AntineoplasticTesticular NeoplasmsFollow-Up StudiesCarcinoma, Squamous CellSignal TransductionNauseaCamptothecinDNA FragmentationNeutropeniaAntineoplastic Agents, AlkylatingHead and Neck NeoplasmsInfusions, IntravenousDrug Screening Assays, AntitumorDrug SynergismMitochondriaLeukopeniaMitomycinbcl-2-Associated X ProteinAutophagySalvage TherapyTumor Suppressor Protein p53Neoplasms, Germ Cell and EmbryonalDNA DamageNeoplasm MetastasisIn Situ Nick-End LabelingStomach NeoplasmsCaspase InhibitorsProspective StudiesCytarabineReactive Oxygen SpeciesCells, CulturedTegafurRadiotherapy, AdjuvantAnthracyclinesKaplan-Meier EstimateOsteosarcomaAntibiotics, AntineoplasticOrganoplatinum CompoundsVindesineAntiemeticsChemotherapy, Cancer, Regional PerfusionCarmustineGerminomaPlatinum CompoundsCell ProliferationCell LineDNA AdductsCarcinomaDeath, Sudden, CardiacPoly(ADP-ribose) PolymerasesRadiotherapy